• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Reconsidering Prostate Cancer Mortality - The Future of PSA Screening.

作者信息

Welch H Gilbert, Albertsen Peter C

机构信息

From the Center for Surgery and Public Health, Brigham and Women's Hospital, Boston (H.G.W.); and the Division of Urology, Department of Surgery, University of Connecticut Health Center, Farmington (P.C.A.).

出版信息

N Engl J Med. 2020 Apr 16;382(16):1557-1563. doi: 10.1056/NEJMms1914228.

DOI:10.1056/NEJMms1914228
PMID:32294352
Abstract
摘要

相似文献

1
Reconsidering Prostate Cancer Mortality - The Future of PSA Screening.重新审视前列腺癌死亡率——前列腺特异性抗原筛查的未来
N Engl J Med. 2020 Apr 16;382(16):1557-1563. doi: 10.1056/NEJMms1914228.
2
Prostate-specific antigen screening for prostate cancer in older men in the United States of America.美国老年男性前列腺癌的前列腺特异性抗原筛查。
Gerontology. 2012;58(4):331-6. doi: 10.1159/000334242. Epub 2012 Feb 16.
3
PSA Screening for Prostate Cancer: Why Saying No is a High-Value Health Care Choice.前列腺特异性抗原（PSA）筛查用于前列腺癌：为何说“不”是高价值的医疗保健选择。
J Natl Compr Canc Netw. 2015 Dec;13(12):1566-74. doi: 10.6004/jnccn.2015.0182.
4
Structured Population-based Prostate-specific Antigen Screening for Prostate Cancer: The European Association of Urology Position in 2019.基于人群的前列腺特异性抗原筛查前列腺癌：欧洲泌尿外科学会 2019 年立场声明。
Eur Urol. 2019 Aug;76(2):142-150. doi: 10.1016/j.eururo.2019.04.033. Epub 2019 May 12.
5
Long-term consequences of the USPSTF Grade D recommendation for prostate-specific antigen screening.美国预防服务工作组（USPSTF）对前列腺特异性抗原筛查的D级推荐的长期后果。
Cancer. 2020 Feb 15;126(4):694-696. doi: 10.1002/cncr.32605. Epub 2019 Dec 3.
6
Why are a high overdiagnosis probability and a long lead time for prostate cancer screening so important?为什么前列腺癌筛查的高过度诊断概率和长领先时间如此重要？
J Natl Cancer Inst. 2009 Mar 18;101(6):362-3. doi: 10.1093/jnci/djp028. Epub 2009 Mar 10.
7
Balancing the harms and benefits of early detection of prostate cancer.权衡前列腺癌早期检测的危害和益处。
Cancer. 2010 Oct 15;116(20):4857-65. doi: 10.1002/cncr.25474.
8
Prostate Cancer Screening and the Associated Controversy.前列腺癌筛查及其相关争议。
Surg Clin North Am. 2015 Oct;95(5):1023-39. doi: 10.1016/j.suc.2015.05.001. Epub 2015 Jun 23.
9
Prevention of Prostate Cancer Morbidity and Mortality: Primary Prevention and Early Detection.前列腺癌发病率和死亡率的预防：一级预防与早期检测
Med Clin North Am. 2017 Jul;101(4):787-806. doi: 10.1016/j.mcna.2017.03.009.
10
Prostate-Specific Antigen-Based Screening for Prostate Cancer: Evidence Report and Systematic Review for the US Preventive Services Task Force.基于前列腺特异性抗原的前列腺癌筛查：美国预防服务工作组的证据报告和系统评价。
JAMA. 2018 May 8;319(18):1914-1931. doi: 10.1001/jama.2018.3712.

引用本文的文献

1
Incidence, mortality, and risk factors of bladder, kidney, prostate and testicular cancers in China and comparisons with the United States, the United Kingdom, Japan, and the Republic of Korea: an up-to-date overview based on the Global Burden of Disease 2021.中国膀胱癌、肾癌、前列腺癌和睾丸癌的发病率、死亡率及危险因素，以及与美国、英国、日本和韩国的比较：基于《2021年全球疾病负担》的最新综述
Exp Hematol Oncol. 2025 Aug 6;14(1):103. doi: 10.1186/s40164-025-00694-9.
2
Untargeted metabolomics revealed urinary metabolic pattern for discriminating prostate cancer from benign prostatic hyperplasia in Chinese participants.非靶向代谢组学揭示了中国参与者中区分前列腺癌与良性前列腺增生的尿液代谢模式。
Front Oncol. 2025 Jun 25;15:1604169. doi: 10.3389/fonc.2025.1604169. eCollection 2025.
3
Developing a model for predicting suicide risk among prostate cancer survivors.建立一个预测前列腺癌幸存者自杀风险的模型。
Front Med (Lausanne). 2025 Apr 10;12:1483266. doi: 10.3389/fmed.2025.1483266. eCollection 2025.
4
The Older the Patients, the More Aggressive the Prostate Cancer Detected Even Among Those With a Prostate-Specific Antigen Level Below the Low-Risk Threshold: Analysis Using Nationwide Korean Data.患者年龄越大，即便前列腺特异性抗原水平低于低风险阈值，所检测出的前列腺癌侵袭性越强：基于韩国全国数据的分析
J Korean Med Sci. 2025 Apr 21;40(15):e57. doi: 10.3346/jkms.2025.40.e57.
5
Value of baseline PSA in predicting prostate cancer diagnosis and death. Spanish arm of the European Randomized Study of Screening for Prostate Cancer.基线前列腺特异性抗原在预测前列腺癌诊断和死亡中的价值。欧洲前列腺癌筛查随机研究的西班牙分支。
Cent European J Urol. 2024;77(3):383-388. doi: 10.5173/ceju.2024.31.R1. Epub 2024 Sep 1.
6
Urology on a changing planet: links between climate change and urological disease.变化中的星球上的泌尿学：气候变化与泌尿系统疾病之间的联系。
Nat Rev Urol. 2025 Apr;22(4):208-222. doi: 10.1038/s41585-024-00979-4. Epub 2025 Jan 28.
7
PSA bounce: understanding temporal fluctuations in prostate cancer after external radiotherapy.前列腺特异性抗原反弹：理解外照射放疗后前列腺癌的时间波动情况
Clin Transl Oncol. 2024 Dec 20. doi: 10.1007/s12094-024-03816-7.
8
Transperineal prostate biopsy guided by which ultrasound transducer: transrectal or transperineal: a retrospective study.经直肠或经会阴超声引导的经会阴前列腺活检：一项回顾性研究。
PeerJ. 2024 Nov 11;12:e18424. doi: 10.7717/peerj.18424. eCollection 2024.
9
Prostate-specific antigen, digital rectal examination, and prostate cancer detection: A study based on more than 7000 transrectal ultrasound-guided prostate biopsies in Ghana.前列腺特异性抗原、直肠指检与前列腺癌检测：一项基于加纳7000多例经直肠超声引导下前列腺活检的研究。
Transl Oncol. 2025 Jan;51:102163. doi: 10.1016/j.tranon.2024.102163. Epub 2024 Nov 2.
10
Advancements in Biomarkers of Prostate Cancer: A Review.前列腺癌生物标志物的研究进展：综述。
Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241290029. doi: 10.1177/15330338241290029.